The many alternative faces of macrophage activation

Frontiers in Immunology

Volumn 6, Issue JUL, 2015, Pages

  Hume, David A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Activation; Colony stimulating factor; Lipopolysaccharide; Macrophage; Transcriptomics

Indexed keywords

ALPHA INTERFERON; CATHEPSIN E; CD14 ANTIGEN; CD68 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 34; INTERLEUKIN 4; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR HOXA9;

ANTIGEN PRESENTING CELL; DOWN REGULATION; ENDOCYTOSIS; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; NONHUMAN; ONCOGENE MYB; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

EID: 84938499317     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00370     Document Type: Review

References (112)

1. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 128:415-35. doi:10.1084/jem.128.3.415
2. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science (2010) 327:656-61. doi:10.1126/science.1178331
3. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 5:953-64. doi:10.1038/nri1733
4. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol (2006) 18:49-53. doi:10.1016/j.coi.2005.11.008
5. Hume DA. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol (2008) 1:432-41. doi:10.1038/mi.2008.36
6. Hume DA, MacDonald KP. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood (2012) 119:1810-20. doi:10.1182/blood-2011-09-379214
7. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature (2013) 496:445-55. doi:10.1038/nature12034
8. Jenkins SJ, Hume DA. Homeostasis in the mononuclear phagocyte system. Trends Immunol (2014) 35(8):358-67. doi:10.1016/j.it.2014.06.006
9. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 330:841-5. doi:10.1126/science.1194637
10. Chorro L, Sarde A, Li M, Woollard KJ, Chambon P, Malissen B, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med (2009) 206:3089-100. doi:10.1084/jem.20091586
11. Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med (2012) 209:1167-81. doi:10.1084/jem.20120340
12. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 336:86-90. doi:10.1126/science.1219179
13. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity (2013) 38:792-804. doi:10.1016/j.immuni.2013.04.004
14. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity (2013) 38:79-91. doi:10.1016/j.immuni.2012.12.001
15. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol (2013) 14:986-95. doi:10.1038/ni.2705
16. Liu H, Leo C, Chen X, Wong BR, Williams LT, Lin H, et al. The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. Biochim Biophys Acta (2012) 1824(7):938-45. doi:10.1016/j.bbapap.2012.04.012
17. Ma X, Lin WY, Chen Y, Stawicki S, Mukhyala K, Wu Y, et al. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure (2012) 20:676-87. doi:10.1016/j.str.2012.02.010
18. Garceau V, Smith J, Paton IR, Davey M, Fares MA, Sester DP, et al. Pivotal advance: avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products. J Leukoc Biol (2010) 87:753-64. doi:10.1189/jlb.0909624
19. Nandi S, Gokhan S, Dai XM, Wei S, Enikolopov G, Lin H, et al. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev Biol (2012) 367:100-13. doi:10.1016/j.ydbio.2012.03.026
20. Nakamichi Y, Udagawa N, Takahashi N. IL-34 and CSF-1: similarities and differences. J Bone Miner Metab (2013) 31:486-95. doi:10.1007/s00774-013-0476-3
21. MacDonald KP, Palmer JS, Cronau S, Seppanen E, Olver S, Raffelt NC, et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue-and tumor-associated macrophages but does not inhibit inflammation. Blood (2010) 116:3955-63. doi:10.1182/blood-2010-02-266296
22. Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ, et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood (2003) 101:1155-63. doi:10.1182/blood-2002-02-0569
23. Hume DA. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J Leukoc Biol (2011) 89:525-38. doi:10.1189/jlb.0810472
24. Freeman TC, Goldovsky L, Brosch M, Van Dongen S, Maziere P, Grocock RJ, et al. Construction, visualisation, and clustering of transcription networks from microarray expression data. PLoS Comput Biol (2007) 3:2032-42. doi:10.1371/journal.pcbi.0030206
25. Theocharidis A, Van Dongen S, Enright AJ, Freeman TC. Network visualization and analysis of gene expression data using BioLayout express (3D). Nat Protoc (2009) 4:1535-50. doi:10.1038/nprot.2009.177
26. Hume DA, Summers KM, Raza S, Baillie JK, Freeman TC. Functional clustering and lineage markers: insights into cellular differentiation and gene function from large-scale microarray studies of purified primary cell populations. Genomics (2010) 95:328-38. doi:10.1016/j.ygeno.2010.03.002
27. Mabbott NA, Kenneth Baillie J, Hume DA, Freeman TC. Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations. Immunobiology (2010) 215:724-36. doi:10.1016/j.imbio.2010.05.012
28. Mabbott NA, Baillie JK, Brown H, Freeman TC, Hume DA. An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics (2013) 14:632. doi:10.1186/1471-2164-14-632
29. Freeman TC, Ivens A, Baillie JK, Beraldi D, Barnett MW, Dorward D, et al. A gene expression atlas of the domestic pig. BMC Biol (2012) 10:90. doi:10.1186/1741-7007-10-90
30. van Dam S, Craig T, De Magalhaes JP. GeneFriends: a human RNA-seq-based gene and transcript co-expression database. Nucleic Acids Res (2015) 43:D1124-32. doi:10.1093/nar/gku1042
31. Rehli M, Lichanska A, Cassady AI, Ostrowski MC, Hume DA. TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. J Immunol (1999) 162:1559-65.
32. Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, et al. Genetic and physical interactions between microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem (2001) 276:36703-10. doi:10.1074/jbc.M106418200
33. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol (2008) 181:5829-35. doi:10.4049/jimmunol.181.9.5829
34. Hume DA, Mabbott N, Raza S, Freeman TC. Can DCs be distinguished from macrophages by molecular signatures?. Nat Immunol (2013) 14:187-9. doi:10.1038/ni.2516
35. Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity (2014) 40:642-56. doi:10.1016/j.immuni.2014.04.016
36. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev (2010) 234:45-54. doi:10.1111/j.0105-2896.2009.00879.x
37. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 31:563-604. doi:10.1146/annurev-immunol-020711-074950
38. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol (2012) 13:888-99. doi:10.1038/ni.2370
39. Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol (2012) 13:1118-28. doi:10.1038/ni.2419
40. Consortium (The FANTOM Consortium), Forrest AR, Kawaji H, Rehli M, Baillie JK, De Hoon MJ, et al. A promoter-level mammalian expression atlas. Nature (2014) 507:462-70. doi:10.1038/nature13182
41. Joshi A, Pooley C, Freeman TC, Lennartsson A, Babina M, Schmidl C, et al. Technical advance: transcription factor, promoter, and enhancer utilization in human myeloid cells. J Leukoc Biol (2015) 97:985-95. doi:10.1189/jlb.6TA1014-477RR
42. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 137:1142-62. doi:10.1084/jem.137.5.1142
43. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci (2014) 17:131-43. doi:10.1038/nn.3599
44. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol (1984) 2:283-318. doi:10.1146/annurev.iy.02.040184.001435
45. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2004) 75:163-89. doi:10.1189/jlb.0603252
46. Taylor PR, Gordon S. Monocyte heterogeneity and innate immunity. Immunity (2003) 19:2-4. doi:10.1016/S1074-7613(03)00178-X
47. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, et al. Macrophage polarization in tumour progression. Semin Cancer Biol (2008) 18:349-55. doi:10.1016/j.semcancer.2008.03.004
48. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity (2010) 32:593-604. doi:10.1016/j.immuni.2010.05.007
49. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 122:787-95. doi:10.1172/JCI59643
50. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 11:750-61. doi:10.1038/nri3088
51. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci (2008) 13:453-61. doi:10.2741/2692
52. Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood (2013) 121:e57-69. doi:10.1182/blood-2012-06-436212
53. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 41:14-20. doi:10.1016/j.immuni.2014.06.008
54. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, et al. Systems biology approaches identify ATF3 as a negative regulator of toll-like receptor 4. Nature (2006) 441:173-8. doi:10.1038/nature04768
55. Nilsson R, Bajic VB, Suzuki H, Di Bernardo D, Bjorkegren J, Katayama S, et al. Transcriptional network dynamics in macrophage activation. Genomics (2006) 88:133-42. doi:10.1016/j.ygeno.2006.03.022
56. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity (2010) 32:317-28. doi:10.1016/j.immuni.2010.02.008
57. Bhatt DM, Pandya-Jones A, Tong AJ, Barozzi I, Lissner MM, Natoli G, et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell (2012) 150:279-90. doi:10.1016/j.cell.2012.05.043
58. Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, et al. Effect of natural genetic variation on enhancer selection and function. Nature (2013) 503:487-92. doi:10.1038/nature12615
59. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, et al. Latent enhancers activated by stimulation in differentiated cells. Cell (2013) 152:157-71. doi:10.1016/j.cell.2012.12.018
60. Wells CA, Ravasi T, Hume DA. Inflammation suppressor genes: please switch out all the lights. J Leukoc Biol (2005) 78:9-13. doi:10.1189/jlb.1204710
61. Raza S, Barnett MW, Barnett-Itzhaki Z, Amit I, Hume DA, Freeman TC. Analysis of the transcriptional networks underpinning the activation of murine macrophages by inflammatory mediators. J Leukoc Biol (2014) 96(2):167-83. doi:10.1189/jlb.6HI0313-169R
62. Wells CA, Ravasi T, Faulkner GJ, Carninci P, Okazaki Y, Hayashizaki Y, et al. Genetic control of the innate immune response. BMC Immunol (2003) 4:5. doi:10.1186/1471-2172-4-5
63. Schilling E, El Chartouni C, Rehli M. Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res (2009) 19:2028-35. doi:10.1101/gr.095562.109
64. Tulone C, Tsang J, Prokopowicz Z, Grosvenor N, Chain B. Natural cathepsin E deficiency in the immune system of C57BL/6J mice. Immunogenetics (2007) 59:927-35. doi:10.1007/s00251-007-0256-0
65. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature (2011) 480:104-8. doi:10.1038/nature10653
66. Rehli M, Sulzbacher S, Pape S, Ravasi T, Wells CA, Heinz S, et al. Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J Immunol (2005) 174:7111-22. doi:10.4049/jimmunol.174.11.7111
67. Schroder K, Irvine KM, Taylor MS, Bokil NJ, Le Cao KA, Masterman KA, et al. Conservation and divergence in toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci U S A (2012) 109:E944-53. doi:10.1073/pnas.1110156109
68. Fairbairn L, Kapetanovic R, Sester DP, Hume DA. The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease. J Leukoc Biol (2011) 89:855-71. doi:10.1189/jlb.1110607
69. Kapetanovic R, Fairbairn L, Beraldi D, Sester DP, Archibald AL, Tuggle CK, et al. Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol (2012) 188:3382-94. doi:10.4049/jimmunol.1102649
70. Schultze JL, Freeman T, Hume DA, Latz E. A transcriptional perspective on human macrophage biology. Semin Immunol (2015) 27:44-50. doi:10.1016/j.smim.2015.02.001
71. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8:958-69. doi:10.1038/nri2448
72. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity (2014) 40:274-88. doi:10.1016/j.immuni.2014.01.006
73. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol (2009) 9:259-70. doi:10.1038/nri2528
74. Doig TN, Hume DA, Theocharidis T, Goodlad JR, Gregory CD, Freeman TC. Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genomics (2013) 14:469. doi:10.1186/1471-2164-14-469
75. Kapetanovic R, Fairbairn L, Downing A, Beraldi D, Sester DP, Freeman TC, et al. The impact of breed and tissue compartment on the response of pig macrophages to lipopolysaccharide. BMC Genomics (2013) 14:581. doi:10.1186/1471-2164-14-581
76. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, Lau E, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science (2014) 343:1246949. doi:10.1126/science.1246949
77. Hume DA, Freeman TC. Transcriptomic analysis of mononuclear phagocyte differentiation and activation. Immunol Rev (2014) 262:74-84. doi:10.1111/imr.12211
78. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 484:519-23. doi:10.1038/nature10921
79. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood (2007) 109:2066-77. doi:10.1182/blood-2006-02-002477
80. Li H, Ice JA, Lessard CJ, Sivils KL. Interferons in Sjogren's syndrome: genes, mechanisms, and effects. Front Immunol (2013) 4:290. doi:10.3389/fimmu.2013.00290
81. Ronnblom L, Eloranta ML. The interferon signature in autoimmune diseases. Curr Opin Rheumatol (2013) 25:248-53. doi:10.1097/BOR.0b013e32835c7e32
82. Chiche L, Jourde-Chiche N, Whalen E, Presnell S, Gersuk V, Dang K, et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol (2014) 66(6):1583-95. doi:10.1002/art.38628
83. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 138:129-45. doi:10.1016/j.cell.2009.05.047
84. Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol (2009) 9:692-703. doi:10.1038/nri2634
85. Ross IL, Dunn TL, Yue X, Roy S, Barnett CJ, Hume DA. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes. Oncogene (1994) 9:121-32.
86. Kueh HY, Champhekar A, Nutt SL, Elowitz MB, Rothenberg EV. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science (2013) 341:670-3. doi:10.1126/science.1240831
87. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell (2010) 38:576-89. doi:10.1016/j.molcel.2010.05.004
88. Heinz S, Glass CK. Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies. Curr Top Microbiol Immunol (2012) 356:1-15. doi:10.1007/82_2011_142
89. Barozzi I, Simonatto M, Bonifacio S, Yang L, Rohs R, Ghisletti S, et al. Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers. Mol Cell (2014) 54:844-57. doi:10.1016/j.molcel.2014.04.006
90. Gosselin D, Glass CK. Epigenomics of macrophages. Immunol Rev (2014) 262:96-112. doi:10.1111/imr.12213
91. Mancino A, Termanini A, Barozzi I, Ghisletti S, Ostuni R, Prosperini E, et al. A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages. Genes Dev (2015) 29:394-408. doi:10.1101/gad.257592.114
92. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science (2005) 309:1559-63. doi:10.1126/science.1112014
93. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 38:626-35. doi:10.1038/ng1789
94. Balwierz PJ, Carninci P, Daub CO, Kawai J, Hayashizaki Y, Van Belle W, et al. Methods for analyzing deep sequencing expression data: constructing the human and mouse promoterome with deepCAGE data. Genome Biol (2009) 10:R79. doi:10.1186/gb-2009-10-7-r79
95. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 5:446-58. doi:10.1038/nri1630
96. Wells CA, Chalk AM, Forrest A, Taylor D, Waddell N, Schroder K, et al. Alternate transcription of the toll-like receptor signaling cascade. Genome Biol (2006) 7:R10. doi:10.1186/gb-2006-7-2-r10
97. Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell (2013) 51:310-25. doi:10.1016/j.molcel.2013.07.010
98. Lam MT, Li W, Rosenfeld MG, Glass CK. Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci (2014) 39:170-82. doi:10.1016/j.tibs.2014.02.007
99. Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al. An atlas of active enhancers across human cell types and tissues. Nature (2014) 507:455-61. doi:10.1038/nature12787
100. Arner E, Daub CO, Vitting-Seerup K, Andersson R, Lilje B, Drablos F, et al. Gene regulation. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science (2015) 347:1010-4. doi:10.1126/science.1259418
101. Perlino E, Cortese R, Ciliberto G. The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. EMBO J (1987) 6:2767-71.
102. Shalek AK, Satija R, Adiconis X, Gertner RS, Gaublomme JT, Raychowdhury R, et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature (2013) 498:236-40. doi:10.1038/nature12172
103. Ravasi T, Wells C, Forest A, Underhill DM, Wainwright BJ, Aderem A, et al. Generation of diversity in the innate immune system: macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes. J Immunol (2002) 168:44-50. doi:10.4049/jimmunol.168.1.44
104. Pereira JP, Girard R, Chaby R, Cumano A, Vieira P. Monoallelic expression of the murine gene encoding toll-like receptor 4. Nat Immunol (2003) 4:464-70. doi:10.1038/ni917
105. Lee TK, Covert MW. High-throughput, single-cell NF-kappaB dynamics. Curr Opin Genet Dev (2010) 20:677-83. doi:10.1016/j.gde.2010.08.005
106. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol (2010) 11:373-84. doi:10.1038/ni.1863
107. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell (2010) 140:805-20. doi:10.1016/j.cell.2010.01.022
108. Hume DA. Probability in transcriptional regulation and its implications for leukocyte differentiation and inducible gene expression. Blood (2000) 96:2323-8.
109. Amit I, Garber M, Chevrier N, Leite AP, Donner Y, Eisenhaure T, et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science (2009) 326:257-63. doi:10.1126/science.1179050
110. Suzuki H, Forrest AR, Van Nimwegen E, Daub CO, Balwierz PJ, Irvine KM, et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 41:553-62. doi:10.1038/ng.375
111. Reddy MA, Yang BS, Yue X, Barnett CJ, Ross IL, Sweet MJ, et al. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. J Exp Med (1994) 180:2309-19. doi:10.1084/jem.180.6.2309
112. Robert C, Lu X, Law A, Freeman TC, Hume DA. Macrophages.com: an on-line community resource for innate immunity research. Immunobiology (2011) 216:1203-11. doi:10.1016/j.imbio.2011.07.025